NCCN Announces Funding for a Prostate Cancer Resea | Newswise
Newswise — PLYMOUTH MEETING, PA [December 11, 2024] — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced funding of a project that will underpin innovative research on optimal management of side effects secondary to treatment with poly ADP ribose polymerase inhibitors (PARPi). The award is supported by Pfizer Global Medical Grants…